Crossmark

Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study

Crossref DOI link: https://doi.org/10.1186/s13613-017-0244-y

Published Print: 2017

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tagami, Takashi

Matsui, Hiroki

Moroe, Yuuta

Fukuda, Reo

Shibata, Ami

Tanaka, Chie

Unemoto, Kyoko

Fushimi, Kiyohide

Yasunaga, Hideo
Funding

Funding for this research was provided by:

Grants for Research on Policy Planning and Evaluation, Ministry of Health, Labour and Welfare, Japan (H28-Policy-Designated-009)

Grants for Research on Policy Planning and Evaluation, Ministry of Health, Labour and Welfare, Japan (H28-Policy-Designated-009)

Grant-in-Aid for Scientific Research, Japan (KAKENHI-15H05685)
License Information

Text and Data Mining valid from 2017-01-01

Text and Data Mining valid from 2017-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-017-0244-y

Content Type: article

Copyright: Copyright © 2017 The Author(s) 2017. Published by Elsevier Masson SAS